Authors: LOUIE T MORGAN B STANDIFORD HC

Citation: T. Louie et al., FACET AND FACET-JOINT INFECTIONS - CASE-REPORT AND REVIEW, Clinical infectious diseases, 26(2), 1998, pp. 510-512

Authors: HAFNER R BETHEL J POWER M LANDRY B BANACH M MOLE L STANDIFORD HC FOLLANSBEE S KUMAR P RAASCH R COHN D MUSHATT D DRUSANO G

Citation: R. Hafner et al., TOLERANCE AND PHARMACOKINETIC INTERACTIONS OF RIFABUTIN AND CLARITHROMYCIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED VOLUNTEERS, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 631-639

Authors: NIU MT BETHEL J HOLODNIY M STANDIFORD HC SCHNITTMAN SM

Citation: Mt. Niu et al., ZIDOVUDINE TREATMENT IN PATIENTS WITH PRIMARY (ACUTE) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 178(1), 1998, pp. 80-91

Authors: BILELLO JA EISEMAN JL STANDIFORD HC DRUSANO GL

Citation: Ja. Bilello et al., IMPACT OF DOSING SCHEDULE UPON SUPPRESSION OF A RETROVIRUS IN A MURINE MODEL OF AIDS ENCEPHALOPATHY, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 628-631

Authors: STANDIFORD HC WALSH TJ DRUSANO GL TATEM BA TOWNSEND RJ

Citation: Hc. Standiford et al., SERUM INHIBITORY AND BACTERICIDAL ACTIVITY AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN VOLUNTEERS RECEIVING NOVOBIOCIN AND RIFAMPIN ALONE AND IN COMBINATION, Diagnostic microbiology and infectious disease, 17(2), 1993, pp. 135-142

Authors: WALSH TJ STANDIFORD HC REBOLI AC JOHN JF MULLIGAN ME RIBNER BS MONTGOMERIE JZ GOETZ MB MAYHALL CG RIMLAND D STEVENS DA HANSEN SL GERARD GC RAGUAL RJ

Citation: Tj. Walsh et al., RANDOMIZED DOUBLE-BLINDED TRIAL OF RIFAMPIN WITH EITHER NOVOBIOCIN ORTRIMETHOPRIM-SULFAMETHOXAZOLE AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS COLONIZATION - PREVENTION OF ANTIMICROBIAL RESISTANCE ANDEFFECT OF HOST FACTORS ON OUTCOME, Antimicrobial agents and chemotherapy, 37(6), 1993, pp. 1334-1342